Transcription Factor SAP30 Is Involved in the Activation of NETO2 Gene Expression in Clear Cell Renal Cell Carcinoma


Цитировать

Полный текст

Открытый доступ Открытый доступ
Доступ закрыт Доступ предоставлен
Доступ закрыт Только для подписчиков

Аннотация

Clear cell renal cell carcinoma (ccRCC) is a common oncourological disease with a high mortality level. The incidence of this type of cancer is constantly increasing, while molecular mechanisms involved in the disease initiation and progression remain far from being fully understood. A problem of the search for novel markers is crucial for improvement of diagnosis and therapy of ccRCC. We have previously found that the disease is characterized by increased expression of the NETO2 gene. In the present study, we showed that isoform 1 (NM_018092.4) makes the main contribution to the upregulation of this gene. Using original CrossHub software, “The Cancer Genome Atlas” (TCGA) project data were analyzed to identify possible mechanisms of NETO2 gene activation in ccRCC. The absence of significant contribution of methylation to the increase of mRNA level of the gene was observed. At the same time, a number of genes encoding transcription factors, which could potentially regulate the expression of NETO2 in ccRCC, were identified. Three such genes (MYCBP, JMY, and SAP30) were selected for the further analysis of their mRNA levels in a set of ccRCC samples with quantitative PCR. We showed a significant increase in mRNA level of one of the examined genes, SAP30, and revealed its positive correlation with NETO2 gene expression. Thus, upregulation of NETO2 gene is first stipulated by the isoform 1 (NM_018092.4), and the probable mechanism of its activation is associated with the increased expression of SAP30 transcription factor.

Об авторах

A. Snezhkina

Engelhardt Institute of Molecular Biology

Email: rhizamoeba@mail.ru
Россия, Moscow, 119991

K. Nyushko

National Medical Research Radiological Center

Email: rhizamoeba@mail.ru
Россия, Moscow, 125284

A. Zaretsky

Pirogov Russian National Research Medical University; Evrogen Lab LLC

Email: rhizamoeba@mail.ru
Россия, Moscow, 117997; Moscow, 117437

D. Shagin

Pirogov Russian National Research Medical University

Email: rhizamoeba@mail.ru
Россия, Moscow, 117997

A. Sadritdinova

Engelhardt Institute of Molecular Biology; National Medical Research Radiological Center

Email: rhizamoeba@mail.ru
Россия, Moscow, 119991; Moscow, 125284

M. Fedorova

Engelhardt Institute of Molecular Biology

Email: rhizamoeba@mail.ru
Россия, Moscow, 119991

Z. Guvatova

Engelhardt Institute of Molecular Biology

Email: rhizamoeba@mail.ru
Россия, Moscow, 119991

I. Abramov

Engelhardt Institute of Molecular Biology

Email: rhizamoeba@mail.ru
Россия, Moscow, 119991

E. Pudova

Engelhardt Institute of Molecular Biology

Email: rhizamoeba@mail.ru
Россия, Moscow, 119991

B. Alekseev

National Medical Research Radiological Center

Email: rhizamoeba@mail.ru
Россия, Moscow, 125284

A. Dmitriev

Engelhardt Institute of Molecular Biology

Email: rhizamoeba@mail.ru
Россия, Moscow, 119991

A. Kudryavtseva

Engelhardt Institute of Molecular Biology; National Medical Research Radiological Center

Автор, ответственный за переписку.
Email: rhizamoeba@mail.ru
Россия, Moscow, 119991; Moscow, 125284

Дополнительные файлы

Доп. файлы
Действие
1. JATS XML

© Pleiades Publishing, Inc., 2018

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).